5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide
C23H23F2N3O5S — CID 135184800
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide
5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide (PubChem CID 135184800) has the molecular formula C23H23F2N3O5S and a molecular weight of 491.52 g/mol. Its IUPAC name is 5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide.
Molecular Properties
| Compound Name | 5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide |
|---|---|
| PubChem CID | 135184800 |
| Molecular Formula | C23H23F2N3O5S |
| Molecular Weight | 491.52 g/mol |
| Exact Mass | 491.13 |
| IUPAC Name | 5-[(2,4-difluorophenyl)sulfonylamino]-N-(oxan-4-yl)-2-oxospiro[1H-indole-3,1'-cyclobutane]-7-carboxamide |
| SMILES | O=C(NC1CCOCC1)c1cc(NS(=O)(=O)c2ccc(F)cc2F)cc2c1NC(=O)C21CCC1 |
| InChI | InChI=1S/C23H23F2N3O5S/c24-13-2-3-19(18(25)10-13)34(31,32)28-15-11-16(21(29)26-14-4-8-33-9-5-14)20-17(12-15)23(6-1-7-23)22(30)27-20/h2-3,10-12,14,28H,1,4-9H2,(H,26,29)(H,27,30) |
| InChIKey | OSCIDUATNQUDTH-UHFFFAOYSA-N |
| XLogP | 3.05 |
| TPSA | 113.60 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 491.52 |
| LogP ≤ 5 | 3.05 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135184800 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.